BSMA Africa > Inaugural Conference – Oct. 31-Nov. 1, 2022

A Glimpse into the Conference Session!

A 2 DAY In-Person Event! 

Join industry leaders from around the world for the 1st annual conference of Bio Supply chain Management Alliance Africa. In a world that has changed dramatically since 2020, let’s continue to build the future of the supply chain industry together by providing solutions and innovations that will save more lives. Come and exchange with your colleagues and partners during these days dedicated to supply chain excellence!

DATES:  Monday, October 31 – Tuesday, November 1, 2022

LOCATION: Kigali Marriott Hotel, Kigali, Rwanda

REGISTER:  BUY YOUR TICKET!

HIGHLIGHTS OF THE CONFERENCE PROGRAM

  • HEALTHCARE IN AFRICA: CURRENT REALITY & A LONG TERM VISION
  • HEALTHCARE POLICY ALIGNMENT ACROSS THE AFRICA UNION
  • LESSONS LEARNED FROM COVID-19 VACCINES
  • SUPPLY CHAIN MATURITY OF A NATION OF AFRICA
  • SUPPLY CHAIN CHALLENGES & SOLUTIONS
  • INDIGENOUS BIOPHARMA MANUFACTURING
  • AU COLLABORATION TO COMBAT INFECTIOUS DISEASES
  • WORKFORCE DEVELOPMENT FOR LIFE SCIENCES
  • TECHNOLOGIES DRIVING HEALTHCARE INNOVATIONS
  • EDUCATION FOR SUPPLY CHAIN MANAGEMENT
  • SUSTAINABILITY OF THE ENVIRONMENT
  • WAGING A WAR ON COUNTERFEIT DRUGS

Program 2022

The program is still in progress.  Return as changes take place.

WELCOME ADDRESS: “BUILDIN​G A ​SELF-SUFFICIENT HEALTHCARE CONTINENT OF AFRICA”

Devendra Mishra, Executive Director, BSMA

Franck Toussaint, Managinfg Director, BSMA Europe

ADDRESS OF THE PATRON – MINISTER OF HEALTH, REPUBLIC OF RWANDA:  HEALTHCARE VISION OF THE AFRICA UNION: A PROGRESS REPORT & A CALL TO ACTION!
Dr. Daniel M. Ngamije, Minister of Health, Republic of Rwanda 

SUPPLY CHAIIN OF AFRICA:  BUILDING FOR PROSPERITY
A supply chain is essential for the manufacture, distribution, and consumption of goods and services for a healthy and prosperous economy.  In the case of Life Sciences, life depends on its flawless execution.  Supply chain is the tide that raises all boats.  A critical assessment will be made of the current maturity of the supply chain infrastructure to help achieve the objectives of the African Continent Free Trade Agreement.  The critical links of manufacturing, warehousing, transportation, customer service, technology, and the overall network will be the focus.  A perspective will be presented of how Industry, Technology, Governments, and International Institutions can make Africa be the Growth Story of the century.
Dr. Abdul Samed Muntaka, Senior Lecturer and Former Head of the Department of Supply Chain and Information Systems, Kwame Nkrumah University of Science & Technology

MOONSHOT COLLABORATION TO ADVANCE HEALTHCARE IN THE AFRICAN UNION
Country experts will address the supply chain challenges of healthcare and identify for collaboration in terms of government advocacy,  case studies and best practices adopted, technology deployment, international aid and how to integrate the healthcare supply chains of across the content.
PANEL
Inès Buki, USAID Country Director USAID, Chemonix
Alain Samne, Director, Business Development & Supply Chain, Institut Pasteur de Dakar
Ben Leyka, Chief Executive officer, African Agricultural Council (South Africa)
Azuka Okeke, CEO, African Resource for Excellence in Supply Chain Management
Eric Santkin, Trade and Investment Commissioner, Belgium (based in Rwanda covering Rwanda, Burundi, and Ethiopia)
Reps of Rwanda, DRC, Burundi, Tanzania, Uganda, South Africa (Waiting Confirmation)
Moderator: Devendra Mishra, Executive Director, BSMA

THE COVID-19 PANDEMIC MAKES INDIGENOUS BIO-PHARMA MANUFACTURING IMPERATIVE
A massive population of 1.3 billion people of the Continent of Africa cannot depend on bio-pharmaceutical manufacturing overseas for its wellbeing, security and economic progress. A manufacturing facility supports suppliers, service providers and manufacturing feeders, where building an ecosystem for Life Sciences has to be the strategic goal of a region. The presentation will provide a blueprint for strategically establishing manufacturing nodes where international initiatives of vaccine manufacturing, drug development, information infrastructure, digital health and healthcare education are addressed.
Dr. Prashant Yadav, Think-tank Fellow, Professor, & Researcher. CGDEV, INSEAD and Harvard Med. Supply Chains for Medical Products

OVERCOMING THE CHALLENGES OF EXECUTING THE PHARMACEUTICAL MANUFACTURING PLAN (PMPA) FOR AFRICA: A CALL TO ACTION!
The COVID-19 pandemic exposed Africa’s inadequate capabilities and capacity to manufacture and supply essential drugs and personal protective equipment. Africa sources more than 75 percent of its pharmaceutical imports from the European Union, India, and China. The ratification of the AfCFTA in 2021 will integrate a market of 1.3 billion people where African manufacturers will enjoy economies of scale and scope. How will the proposed solutions of strengthening the regulatory systems; establishment of a one-stop-shop for information; fostering pooled procurement to incentivize local manufacturers; unconstrained purchasing contracts for healthcare products; and pooled procurement to encourage global generic pharmaceutical manufacturers to build plants in Africa and partner where strategic? The presentation will highlight the success of the south and triangular cooperation/collaboration and lessons learned from India and Bangladesh.
Janet Byaruhanga, Senior Program Officer, Public Health, AUD-NEPAD

CAN AFRICA BECOME THE CLINICAL TRIALS POWERHOUSE?
Despite playing host to 17.5% of the global population, the continent is dramatically underrepresented in clinical trials – only 2.5% of clinical trials take place in Africa. The inherent drawbacks, both for the clinical trial sponsors and the African population, will be addressed. The opportunity to conduct comparatively cheap research with a diverse patient population is huge where genetics can be a causal factor for cancer. Furthermore, a lack of clinical research has stymied drug discovery. The success factors of patient enrollment, drug delivery, compliance, monitoring and returns will be presented with best practices in mind.
PANEL
Dr. Nadine Rujeni, Associate Professor of Parasitology, National University of Rwanda
Other Panelists:  Waiting Confirmation
Moderator: Dr. Shevin Jacob, Reader, Sepsis Research, Liverpool School of Tropical Medicine (LSTM) & Co-founder & Director, Walimu (Uganda)

RWANDA MEDICAL SUPPLIES: THE LIFELINE OF RWANDA’S HEALTHCARE
Rwanda Medical Supply Limited is a corporation created and owned by the Government of Rwanda. Presentation will demonstrate how RMS ensures availability of medicines, medical supplies and consumables in the right quantity, with the acceptable quality, to the right place and customers, at the right time and with optimum cost to the Rwandan population. It will highlight the services of 1. Health Commodities Procurement, 2. Inventory Management, 3. Warehouse and Distribution, 4. Quantification and Sock Monitoring, 5. Sales and Marketing, 5. Medical Production, and Systems. A preview of the future will be provided.
Pie Harerimana, CEO, Rwanda Medical Supplies (RMS)

PROCUREMENT & SUPPLY MANAGEMENT (GHSC-PSM) PROJECT (The USAID GLOBAL HEALTH SUPPLY CHAIN PROGRAM)
Presentation of procurement and technical assistance provided to Rwanda to help ensure uninterrupted availability of high-quality health commodities, focusing on those to prevent and treat HIV/AIDS and malaria. Initiatives will include 1. Local capacity strengthening for strengthening health commodity supply chains, 2. a quality management improvement approach for supply chain operations at district pharmacies and health facilities, 3. District pharmacies, to manage the countrywide implementation of a three-month supply of antiretrovirals (ARVs) called the Differentiated Service Delivery Model (DSDM), 4. Monitoring and evaluating the DSDM for supply of health commodities at service delivery points.
Inès Buki, Rwanda Country Director, USAID Global Health Supply Chain Management Project, CHEMONICS

BIOPHARMA MANUFACTURING: ELIMINATING DEPENDENCE ON IMPORTS
Indigenous manufacture of biopharmaceuticals is severely limited in Africa which depends on imports for nearly 80% of its requirements. The foreign companies, who have developed vaccines for COVID-19, are enabling the Africa Union to launch a platform for partnerships which augurs well for drug production in Africa. The manufacturing enterprises will discuss the impediments to establishment and growth and how they can be addressed strategically in the future.
PANEL
Dr. Ranjana Pathak, Global Quality, Medical Affairs and Pharmacovigilance, Dr. Reddy’s Laboratories
BioNTech (Waiting Confirmation)
Moderna (Waiting Confirmation)
Unizima (UNIVERCELLS) (Waiting Confirmation)
Aspen Pharmacare (Waiting Conformation)
Moderator: Franck Toussaint, Managing Director, BSMA Europe

AFRICA UNION COLLABORATION TO COMBAT INFECTIOUS DISEASES
Since the emergence of the Ebola virus in 1976, periodic outbreaks have been a global health challenge, with COVID-19 as an ongoing one. The African regions bear an immense burden of infectious diseases, particularly that of HIV aids, tuberculosis and malaria, and they are an obstacle to human development. HIV aids, tuberculosis and malaria, kill more than 3 million people in the region every year. Medical scientists from various countries will address successful practices for advocacy for greater national health systems; collaboration in research through joint scientific groups for the continent; greater information sharing among CDCs; combined purchasing of lab equipment, reagents and supplies; deployment of digital technology; and governmental policy alignment for accelerated adoption of solutions across the region.
PANEL
Prof. Emmanuel Nakoune, Scientific Director, and Head of Hemorragic Fever Virus Lab, Institut Pasteur, Bangui, Central Africa Republic
Dr. Edgard Valery Adjogoua, Virologist, Department of Virus Epidemics, Institut Pasteur de Côte d’Ivoire
Dr Hervé Kadjo, Department of Epidemic Viruses, Respiratory Viruses Unit, National Influenza Centre, Pasteur Institute of Cote d’Ivoire
Dr. Shevin Jacob, Reader, Sepsis Research, Liverpool School of Tropical Medicine (LSTM) & Co-founder & Director, Walimu, Uganda
Dr. Nadine Rujeni, Associate Professor of Parasitology, National University of Rwanda
Moderator: Maurice Demanou, Consultant, Yellow Fever Regional Laboratory Coordinator for Africa, WHO

DIAGNOSTIC TESTING FOR INFECTIOUS DISEASES – MADE IN AFRICA FOR AFRICA
Diagnostic testing has played a critical role in the management of the COVID-19 pandemic. The presentation will provide insights into diaTROPIX which was launched at the Institut Pasteur of Dakar in 2020 to produce high-performance rapid tests, made in Africa, for Africa. Supported by a competent team the center can meet the diagnostic needs at affordable prices for countries with limited resources for a wide range of infectious diseases that remain major public health challenges. This overcomes the historical constraint of testing capacity being highly centralized, particularly in Low and Low Middle-Income Countries (LMICs) where fragile health systems and exclusive reliance on global supply chains have limited access to testing. It has quickly produced high volumes of SARS-CoV-2 assays for the African market.
Dr. Cheikh Tidiane Diagne, Head of Operations, diaTROPIX (Institut Pasteur de Dakar)

TRANSFORMING NIGERIA’S HEALTHCARE SYSTEM FROM BEING DONOR-DRIVEN TO A REVENUE-GENERATING BUSINESS ENTERPRISE
While the countries of Africa have historically depended on International Healthcare Organizations and NGOs for investment in drug and healthcare services for the masses, the Africa Resource Center for Excellence in Supply Chain Management (ARC_ESM) has enabled the Government of Nigeria to consider healthcare as a business. A revenue generation mindset and a committed to achieving equitable access to medicines and healthcare commodities across Nigeria, the hub for supply chain innovation has enabled the government to proactively engage the Corporate Private Sector in a coordinated manner to improve the public health supply chain system. The presentation will highlight how the unconventional approach has overcome the challenges of insufficient infrastructure and asset optimization, strategic planning and skills capacity so that long term results match Africa’s growth.
Azuka Okeke, CEO, ARC_ESM, Nigeria

OVERCOMING THE ACHILEES HEEL: THE AIRPORTS OF AFRICA
Recognizing that 90% of the drugs, APIs, supplies and equipment are imported into the countries of Africa, the delivery modes of airlines will be addressed to improve capacity, capability and connectivity. The cumbersome processes of handling a shipment through Rwanda customs in terms of regulatory compliance, product quality assurance, temperature-control, storage, documentation management, documentation management and timeliness is a formidable challenge. Discussion will cover how systemic improvements can be made with best practices.
PANEL

Olivier DeFawe, Director – Private Sector Engagement Lead, Village Reach
Samuel Speltdoorn, Cargo Business development Manager, Brussels Airport
Solange Nisingizwe, CEO, Africa World Cargo
Humanitarian Logistics Association (Waiting Confirmation)
Luxembourg Airport, Rwanda Airlines, Air France, Kenya Airways, KLM and DHL (Waiting Confirmation)
Moderator: Frank Van Gelder, Secretary General, Pharma.Aero

COLD CHAIN LOGISTICS FOR PACKAGING, STORAGE & DELIVERY: MEETING THE ARDUOUS CHALLENGE
The distribution of GDP and GMP compliant temperature-sensitive products and services for the pharmaceutical, healthcare, bio-tech, exporters, clinical trial and logistics industries was an unprecedented challenge COVID-19 pandemic, exposing the vulnerability of the Cold Chain infrastructure in Africa. The reality of 50% of the food produced in African countries being wasted was relevant. The technology solutions of packaging, containerization (passive and active), storage, transportation, delivery in the last mile and temperature-monitoring will be presented.
PANEL
Panelists:  Waiting Confirmation
Moderator: Phil Maxson, CEO, Global Cold Chain Logistics Services

The Necessity and Insufficiency of Regional Vaccine Supply for Sustainable Health Outcomes
Regional Vaccine Supply, as a key learning from Covid-19, is a step forward to better pandemic preparedness and response. However, to reach the intended 60% local production of the 2040 goal, well-functioning end-to-end supply chains are a necessary but not a sufficient condition. Zooming out in order to grasp the entire vaccine supply and immunization system is the only sustainable way towards the ultimate systems’ goal: reaching the required immunization levels. This will be illustrated by examples from vaccines and antivirals (HIV) supply.
Dr. Nico Vandaele, Professor, Operations Research & Operations Management, KU Leuven (Belgium)

DIGITAL HEALTH FUTURE: MAKING THE LEAP FROG JUMP!
In a region with inadequate infrastructure and investment for healthcare, digital technology provides solutions for overcoming the deficiencies. Presentation will cover development of digital health policies, strategies and tactical plans to implement digital health technologies across the sector.
PANEL
Panelists:  Waiting Confirmation
Moderator: Dr. Randy Bradley, Associate Professor, Information Systems and Supply Chain Management, Haslam College of Business, University of Tennessee

DELIVERY OF HAZARDOUS MATERIAL TO THE REMOTE AREAS OF AFRICA
The presentation will demonstrate how cost-efficient logistics know-how is combined with dangerous goods expertise to operate in accordance with the highest quality standards to get the job done safely, effectively and hassle-free. With the background in handling of fertilization clinics around the world to move embryos and semen samples for patients, insights will be provided of the disease control division which has emerged as a preferred partner for governmental bodies, research institutes and NGOs, who are working in remote areas around the world to contain infectious diseases and prevent pandemics.
Olivier Kadjata, Business Development, HAZGO

SUPPLY CHAIN MANAGEMENT EDUCATION: PRODUCING HOLISTIC LEADERS FOR COUNTRIES OF AFRICA AND THE WORLD
The supply chain management program of the Kwame Nkrumah University of Science and Technology (KNUST) in Ghana has become a model for the Center for Applied Research and Innovation in Supply Chain-Africa (CARISCA), a global center of excellence for training, generating, and translating supply chain management research and innovations into positive development outcomes for Ghana and across Africa. The presentation will also focus on how leaders are educated to leverage a local and international network of governmental, civil society, and industry partners to connect African researchers, practitioners, and businesses to supply chain assets around the world.
Dr. David Asamoah, Head of the Department of Supply Chain Management & Information Systems, Kwame Nkrumah University of Science & Technology

JOURNEY OF A UNIVERSITY RECOGNIZED AS GARTNER’S BEST GRADUATE PROGRAM FOR SCM IN THE USA FOR 2022
The University of Tennessee at Knoxville was recognized to have the number one program for graduate studies in Supply Chain Management for its thought leadership and talent development. The story will be told of how Haslam College of Business, the hub of the university, has earned a reputation for industry-relevant curriculum, ground-breaking research and top-ranked faculty.  Faculty’s commitment to student development, industry partnerships, practical and relevant curricula and innovative research are helping companies around the globe design more resilient and responsive supply chains for the future. Finally, the program commitment to diversity, equity and inclusiveness and experiential learning will be articulated.
Dr. Randy Bradley, Associate Professor, Information Systems and Supply Chain Management, Haslam College of Business, University of Tennessee

BUILDING A TRIPARTITE COLLABORATION OF UNIVERSITY, INDUSTRY & GOVERNMENT FOR THE ENTREPRENEURIAL GROWTH OF HEALTHCARE IN AFRICA
The three entities of healthcare, namely, government, university and industry, face the super ordinate challenges of saving human lives and improving healthcare through development and delivery of drugs, services and technology. Birth of the biotech and pharmaceutical industries has generally been in the laboratories of universities and research institutions across the world. The panel will focus on best practices of universities in Africa, Europe and the USA. The stakeholders will explore how the efficacy of drug development, commercialization of the intellectual property and delivery of patient care can be accelerated through collaboration. Unleashing the entrepreneurial energy in healthcare has to be a Made in Africa strategy.
PANEL
Dr. David Asamoah, Head of the Department of Supply Chain Management & Information Systems, Kwame Nkrumah University of Science & Technology
Dr. Randy Bradley, Associate Professor, Information Systems and Supply Chain Management, Haslam College of Business, University of Tennessee
Dr. Nico Vandaele, Professor, Operations Research & Operations Management, KU LEUVEN
Government Officer: TBA
Industry Executive: TBA
Moderator: Devendra Mishra, Executive Director, BSMA

DRONE DELIVERY OVERCOMES LACK OF INFRASRUCTURE IN AFRICA
From powering Rwanda’s national blood delivery network and Ghana’s COVID-19 vaccine distribution, to providing on-demand home delivery and bring care into the home, Zipline is transforming the way goods move. By transitioning to clean, electric, instant logistics, it can decarbonize delivery, decrease road congestion, and reduce fossil fuel consumption and air pollution, while providing equitable access for billions of people. The technology is complex but the idea is simple: a teleportation service that delivers what you need, when you need it.  Zipline is inspiring people, governments, and businesses to imagine what is possible when goods can move as seamlessly as information.
Speaker: Waiting Confirmation

HOW TO WIN THE WAR ON COUNTERFEIT DRUGS, A HEALTHCARE CRISIS?
The proliferation of fake medicines in Africa is a public health crisis that can no longer be ignored, according to a UK charity. The World Health Organization (WHO) says 42% of all fake medicines reported to them between 2013 and 2017 were from Africa. The presentation will cover the initiatives undertaken by several countries of Africa, the successful practices and initiatives adopted, deployment of technology, and packaging solutions.
Speaker: Waiting Confirmation

SUSTAINABILITY: ADDRESSING THE DILEMMA OF ECONOMIC GROWTH & PRESERVATION OF LIFE!
Africa faces serious environmental challenges, including land degradation, deforestation, biodiversity loss and extreme vulnerability to climate change. Sustainability has come to mean that we improve the quality of our lives, protect our ecosystem and preserve natural resources for future generations. In the corporate world, sustainability is associated with an organization’s holistic approach, taking into account everything, from manufacturing to logistics to customer service. The presentation will answer the question: How does Africa exist and develop without depleting natural resources for the future?
PANEL
Panelists: Waiting Confirmation

SPONSORS

GOLD SPONSOR

SILVER SPONSOR

SILVER SPONSOR

BRONZE SPONSOR